Imaging is transforming how clinicians guide cancer immunotherapy, offering visibility into immune response that was previously out of reach. CD8 PET imaging enables visualization and quantification of CD8+ T cell infiltration within tumors, a key marker of anti-tumor activity. As… Read More
Have you ever wondered if there’s a more dynamic and accurate way to assess the efficacy of solid tumor treatments? What if you could predict the day when a patient’s tumor will double in size or shrink by half? Or… Read More
Imaging Endpoints congratulates Anthony G. Letai, MD, PhD, on his well-deserved appointment as the 18th Director of the National Cancer Institute (NCI). Dr. Letai was sworn in on September 29, 2025, by Health and Human Services Secretary Robert F. Kennedy,… Read More
While the Response Assessment in Neuro-Oncology (RANO) Working Group criteria have been pivotal in assessing adult high-grade gliomas, the more recently established Response Assessment in Pediatric Neuro-Oncology (RAPNO) criteria address the unique challenges of evaluating pediatric gliomas, emphasizing the need… Read More
In clinical trials evaluating new therapies for lymphoma, the disease assessments are primarily driven by the Lugano Classification 2014 and rely heavily on PET avidity and changes in measurable disease. These objective measures are critical for standardizing evaluations and ensuring… Read More
Featured Webinar:
Radiologic Analysis of COVID-19 Infection
June 23, 2020
